Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Red ginseng extract protects against carbon tetrachloride-induced liver fibrosis

  • Ki, Sung Hwan (College of Pharmacy, Chosun University) ;
  • Yang, Ji Hye (College of Pharmacy, Chosun University) ;
  • Ku, Sae Kwang (Medical Research Center for Global Herbal Formulation, College of Korean Medicine, Daegu Haany University) ;
  • Kim, Sang Chan (Medical Research Center for Global Herbal Formulation, College of Korean Medicine, Daegu Haany University) ;
  • Kim, Young Woo (Medical Research Center for Global Herbal Formulation, College of Korean Medicine, Daegu Haany University) ;
  • Cho, Il Je (Medical Research Center for Global Herbal Formulation, College of Korean Medicine, Daegu Haany University)
  • Received : 2012.07.17
  • Accepted : 2012.09.11
  • Published : 2013.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Korean red ginseng, the processed root of Panax ginseng Meyer, has been frequently used for various therapeutic purposes in oriental medicine. The present study investigated the possible effect of Korean red ginseng extract (RGE) for the treatment of liver fibrosis in mice injected with carbon tetrachloride ($CCl_4$) for 4 wk. Liver injuries were assessed by blood biochemistry and histopathology in mice treated with $CCl_4$ alone or $CCl_4$+ RGE (30, 100, and 300 mg/kg). Concomitant treatment with RGE and $CCl_4$ (three times/wk for 4 wk) effectively inhibited liver fibrosis as evidenced by decreases in plasma alanine and aspartate aminotransferases, as well as by the percentages of degenerative regions, numbers of degenerative hepatocytes, and collagen accumulation in hepatic parenchyma. Treatment with $CCl_4$ for 4 wk increased mRNA levels of transforming growth factor ${\beta}1$ and plasminogen activator inhibitor 1 in fibrogenic liver, whereas RGE (30, 100, and 300 mg/kg) significantly blocked the induction of fibrogenic genes by $CCl_4$. Similarly, RGE also prevented transforming growth factor ${\beta}1$-mediated induction of fibrogenic genes in human hepatic stellate cell lines. More importantly, RGE markedly reduced the number of ${\alpha}$-smooth muscle actin-positive cells in liver tissue. This study implies that RGE efficaciously protects against the liver fibrosis induced by chronic $CCl_4$ treatment, and may therefore have potential to treat liver disease.

Keywords

References

  1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218. https://doi.org/10.1172/JCI24282
  2. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669. https://doi.org/10.1053/j.gastro.2008.03.003
  3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576. https://doi.org/10.1053/j.gastro.2007.04.061
  4. Simonetti RG, Camma C, Fiorello F, Politi F, D’Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991;36:962-972. https://doi.org/10.1007/BF01297149
  5. Tamayo RP. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology 1983;3:112-120.
  6. Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007;25:185-209. https://doi.org/10.1080/10590500701569398
  7. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998;153:515-525. https://doi.org/10.1016/S0002-9440(10)65594-0
  8. Pierce RA, Glaug MR, Greco RS, Mackenzie JW, Boyd CD, Deak SB. Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats. J Biol Chem 1987;262:1652-1658.
  9. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76-99. https://doi.org/10.1111/j.1582-4934.2006.tb00292.x
  10. Kim HY, Kang KS, Yamabe N, Yokozawa T. Comparison of the effects of Korean ginseng and heat-processed Korean ginseng on diabetic oxidative stress. Am J Chin Med 2008;36:989-1004. https://doi.org/10.1142/S0192415X08006417
  11. Kaneko H, Nakanishi K. Proof of the mysterious efficacy of ginseng: basic and clinical trials. Clinical effects of medical ginseng, Korean red ginseng: specifically, its anti-stress action for prevention of disease. J Pharmacol Sci 2004;95:158-162. https://doi.org/10.1254/jphs.FMJ04001X5
  12. Heo JH, Lee ST, Oh MJ, Park HJ, Shim JY, Chu K, Kim MH: Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with Korean red ginseng. J Ginseng Res 2011; 35:457-461. https://doi.org/10.5142/jgr.2011.35.4.457
  13. Seo EY, Kim WK: Red ginseng extract reduced metastasis of colon cancer cells in vitro and in vivo. J Ginseng Res 2011; 35:315-324. https://doi.org/10.5142/jgr.2011.35.3.315
  14. Wu YL, Wan Y, Jin XJ, OuYang BQ, Bai T, Zhao YQ, Nan JX. 25-OCH3-PPD induces the apoptosis of activated t-HSC/Cl-6 cells via c-FLIP-mediated NF-$\kappa B$ activation. Chem Biol Interact 2011;194:106-112. https://doi.org/10.1016/j.cbi.2011.08.010
  15. Lo YT, Tsai YH, Wu SJ, Chen JR, Chao JC. Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells. J Med Food 2011;14:1135-1143. https://doi.org/10.1089/jmf.2010.1485
  16. Geng J, Peng W, Huang Y, Fan H, Li S. Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats. Eur J Pharmacol 2010;634:162-169. https://doi.org/10.1016/j.ejphar.2010.02.022
  17. Cho IJ, Kim YW, Han CY, Kim EH, Anderson RA, Lee YS, Lee CH, Hwang SJ, Kim SG. E-cadherin antagonizes transforming growth factor $\beta 1$ gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation. Hepatology 2010;52:2053-2064. https://doi.org/10.1002/hep.23931
  18. Cho IJ, Kim SH, Kim SG. Inhibition of TGFbeta1-mediated PAI-1 induction by oltipraz through selective interruption of Smad 3 activation. Cytokine 2006;35:284-294. https://doi.org/10.1016/j.cyto.2006.10.001
  19. Rej R. Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin Chem 1978; 24:1971-1979.
  20. Kruse JJ, Bart CI, Leer JW, Wondergem J. Detection and quantitative measurement of transforming growth factor-beta1 (TGF-beta1) gene expression using a semi-nested competitive PCR assay. Cytokine 1999;11:179-185. https://doi.org/10.1006/cyto.1998.0413
  21. Seki T, Imai H, Uno S, Ariga T, Gelehrter TD. Production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver. Thromb Haemost 1996;75:801-807.
  22. Hagiwara H, Kaizu K, Uriu K, Noguchi T, Takagi I, Qie YL, Seki T, Ariga T. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models. Thromb Res 2003;111:301-309. https://doi.org/10.1016/j.thromres.2003.09.023
  23. Kang KW, Kim YG, Cho MK, Bae SK, Kim CW, Lee MG, Kim SG. Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation. FASEB J 2002;16:1988-1990. https://doi.org/10.1096/fj.02-0406fje
  24. Fujii T, Fuchs BC, Yamada S, Lauwers GY, Kulu Y, Goodwin JM, Lanuti M, Tanabe KK. Mouse model of carbon tetrachloride induced liver fibrosis: histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol 2010;10:79. https://doi.org/10.1186/1471-230X-10-79
  25. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998;17:3091-3100. https://doi.org/10.1093/emboj/17.11.3091
  26. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007;170:1807-1816. https://doi.org/10.2353/ajpath.2007.070112
  27. Lee HJ, Lee YH, Park SK, Kang ES, Kim HJ, Lee YC, Choi CS, Park SE, Ahn CW, Cha BS et al. Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. Metabolism 2009;58:1170-1177. https://doi.org/10.1016/j.metabol.2009.03.015
  28. Lee S, Lee MS, Kim CT, Kim IH, Kim Y. Ginsenoside Rg3 reduces lipid accumulation with AMP-activated protein kinase (AMPK) activation in HepG2 cells. Int J Mol Sci 2012;13:5729-5739. https://doi.org/10.3390/ijms13055729
  29. Kim AD, Kang KA, Zhang R, Lim CM, Kim HS, Kim DH, Jeon YJ, Lee CH, Park J, Chang WY et al. Ginseng saponin metabolite induces apoptosis in MCF-7 breast cancer cells through the modulation of AMP-activated protein kinase. Environ Toxicol Pharmacol 2010;30:134-140. https://doi.org/10.1016/j.etap.2010.04.008
  30. Lim JY, Oh MA, Kim WH, Sohn HY, Park SI. AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300. J Cell Physiol 2012;227:1081-1089. https://doi.org/10.1002/jcp.22824
  31. Caligiuri A, Bertolani C, Guerra CT, Aleffi S, Galastri S, Trappoliere M, Vizzutti F, Gelmini S, Laffi G, Pinzani M et al. Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology 2008;47:668-676.

Cited by

  1. SM-2001 in Hairless Mice vol.116, pp.2, 2015, https://doi.org/10.1111/bcpt.12288
  2. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis vol.35, pp.8, 2014, https://doi.org/10.1038/aps.2014.41
  3. Role of Interleukin-22 in liver diseases vol.63, pp.7, 2014, https://doi.org/10.1007/s00011-014-0727-3
  4. Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis vol.9, pp.1, 2014, https://doi.org/10.1186/s13020-014-0027-4
  5. Protective Effects of Korean Red Ginseng against Alcohol-Induced Fatty Liver in Rats vol.20, pp.6, 2015, https://doi.org/10.3390/molecules200611604
  6. Schisandrae Fructus Supplementation Ameliorates Sciatic Neurectomy-Induced Muscle Atrophy in Mice vol.2015, pp.1942-0994, 2015, https://doi.org/10.1155/2015/872428
  7. The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice vol.36, pp.1, 2015, https://doi.org/10.3892/ijmm.2015.2200
  8. Tacrine, an Oral Acetylcholinesterase Inhibitor, Induced Hepatic Oxidative Damage, Which Was Blocked by Liquiritigenin through GSK3-beta Inhibition vol.38, pp.2, 2015, https://doi.org/10.1248/bpb.b14-00430
  9. Ginseng for Liver Injury: Friend or Foe? vol.3, pp.4, 2016, https://doi.org/10.3390/medicines3040033
  10. Isoliquiritigenin in licorice functions as a hepatic protectant by induction of antioxidant genes through extracellular signal-regulated kinase-mediated NF-E2-related factor-2 signaling pathway vol.55, pp.8, 2016, https://doi.org/10.1007/s00394-015-1051-6
  11. Maxim. Flower Extract Contributes to Protecting Hepatocytes from Oxidative Stress vol.2017, pp.1741-4288, 2017, https://doi.org/10.1155/2017/9253462
  12. -induced hepatic fibrosis in mice through inhibition of STAT-3 vol.91, pp.4, 2018, https://doi.org/10.1111/cbdd.13160
  13. inhibition of p38 and JNK phosphorylation vol.9, pp.2, 2018, https://doi.org/10.1039/C7FO01617D
  14. -induced acute liver damaged mice pp.20487177, 2018, https://doi.org/10.1002/fsn3.893
  15. Beneficial Effects of Korean Red Ginseng in the Progression of Non-Alcoholic Steatohepatitis via FABP4 Modulation vol.46, pp.07, 2018, https://doi.org/10.1142/S0192415X18500817
  16. Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer vol.95, pp.3, 2018, https://doi.org/10.4174/astr.2018.95.3.161
  17. Protective effects of protopanaxatriol on acute liver injury induced by concanavalin A pp.1432-1912, 2018, https://doi.org/10.1007/s00210-018-1567-4
  18. Anti-fibrosis effects of Huisheng oral solution in CCl 4 -induced hepatic fibrosis in rat vol.46, pp.2, 2013, https://doi.org/10.4103/0253-7613.129323
  19. Cyanidin-3-O-β-glucoside Purified from Black Rice Protects Mice against Hepatic Fibrosis Induced by Carbon Tetrachloride via Inhibiting Hepatic Stellate Cell Activation vol.63, pp.27, 2013, https://doi.org/10.1021/acs.jafc.5b02181
  20. Hepatoprotective effects of hoveniae semen cum fructus extracts in ethanol intoxicated mice vol.20, pp.1, 2016, https://doi.org/10.20463/jenb.2016.03.20.1.4
  21. Favorable Hepatoprotective Effects of Gongjin-dan on the Acute Ethanol-induced Liver Damaged C57BL/6 Mice vol.30, pp.4, 2013, https://doi.org/10.15188/kjopp.2016.08.30.4.279
  22. 내분비교란물질 비스페놀 A를 처리한 마우스에서 홍삼 추출물의 간 섬유화 개선 vol.30, pp.2, 2013, https://doi.org/10.7732/kjpr.2017.30.2.125
  23. Dexamethasone에 의하여 유발된 근육 위축 생쥐의 비복근 근섬유에서 apoptosis와 염증 반응에 미치는 오미자 추출물의 영향 vol.25, pp.3, 2013, https://doi.org/10.14374/hfs.2017.25.3.363
  24. Enhancement of Alcohol Metabolism by Ginseng Berry Extract and its Mixed Herbal Beverages: In vitro and in vivo Experiments vol.11, pp.2, 2013, https://doi.org/10.1007/s13530-019-0399-z
  25. Influence of colonic dialysis using Gubenxiezhuo on the distribution of gut microflora in uremia rats vol.234, pp.7, 2019, https://doi.org/10.1002/jcp.27845
  26. Subacute Oral Toxicity and Bacterial Mutagenicity Study of a Mixture of Korean Red Ginseng (Panax ginseng C.A. Meyer) and Salvia plebeia R. Br. Extracts vol.35, pp.3, 2019, https://doi.org/10.5487/tr.2019.35.3.215
  27. Kaempferol attenuates liver fibrosis by inhibiting activin receptor-like kinase 5 vol.23, pp.9, 2019, https://doi.org/10.1111/jcmm.14528
  28. Hepatoprotective Effect of Pericarpium zanthoxyli Extract Is Mediated via Antagonism of Oxidative Stress vol.2020, pp.None, 2013, https://doi.org/10.1155/2020/6761842
  29. Gandou Decoction Decreases Copper Levels and Alleviates Hepatic Injury in Copper-Laden Hepatolenticular Degeneration Model Rats vol.11, pp.None, 2020, https://doi.org/10.3389/fphar.2020.582390
  30. Hormesis and Ginseng: Ginseng Mixtures and Individual Constituents Commonly Display Hormesis Dose Responses, Especially for Neuroprotective Effects vol.25, pp.11, 2020, https://doi.org/10.3390/molecules25112719
  31. Panax ginseng C. A. Meyer as a potential therapeutic agent for organ fibrosis disease vol.15, pp.None, 2013, https://doi.org/10.1186/s13020-020-00400-3
  32. Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism vol.12, pp.None, 2021, https://doi.org/10.3389/fphar.2021.772635
  33. Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-β/Smad Signaling Pathway vol.22, pp.4, 2013, https://doi.org/10.3390/ijms22042041
  34. An Integrated Mutually Oriented “Chemical Profiling-Pharmaceutical Effect” Strategy for Screening Discriminating Markers of Underlying Hepatoprotective Effects to Distinguish Garden-Cultiv vol.26, pp.18, 2021, https://doi.org/10.3390/molecules26185456
  35. Panax Ginseng alleviates thioacetamide-induced liver injury in ovariectomized rats: Crosstalk between inflammation and oxidative stress vol.16, pp.11, 2013, https://doi.org/10.1371/journal.pone.0260507